m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer

Table 2

m6A-related lncRNAs with significant prognostic value in bladder cancer identified by Cox regression analysis.

lncRNA	HR	HR.95L	HR.95H	value
PTOV1-AS2	0.884187841	0.82541651	0.947143811	0.000452515
AC116914.2	0.703807678	0.586719475	0.844262494	0.000154644
EHMT2-AS1	0.27801516	0.137558402	0.5618881	0.000362912
AC004148.1	0.831239083	0.747870199	0.92390152	0.000608535
AL136295.2	0.483637966	0.324345308	0.721162527	0.000365815
KCNQ1OT1	2.155118866	1.384412256	3.354880243	0.000672681
AC104564.3	0.595066715	0.437124167	0.810077371	0.000972718
ATP1B3-AS1	1.207264443	1.090085299	1.337039806	0.000299467
AC073534.2	0.573344516	0.41242174	0.797057724	0.000934795

Note: Cox regression analysis was performed with .